Efficacy and Safety of Microencapsulated Benzoyl Peroxide 3% and Microencapsulated Tretinoin 0.1% (E-Bpo/E-Atra) in Acne Vulgaris: Results from Two Randomized Controlled Clinical Trials

Main Article Content

J Del Rosso
O Levy-Hacham
O Mizrahi


Acne Vulgaris, Benzoyl Peroxide, Topical Retinoid, Safety, Efficacy


Abstract not available.


1. Zaenglein AL, et al. J Am Acad Dermatol. 2016;74:945-973 e933

2. Walsh TR, et al. Lancet Infect Dis.2016;16:e23-33;

3. Matin T, Goodman MB. 2019. Available from http://www.ncbi.nlm.nih.gov/books/ NBK537220/

4. Kawashima M, et al. JDermatol. 2017;44:1212-1218

5. Kircik LH. J Drugs Dermatol. 2013;12:s73-76

6. Sagransky M, et al. Expert Opin Pharmacother.2009;10:2555-2562;

7. Fakhouri T, et al. J Drugs Dermatol. 2009;8:657-661

8. Martin B, et al. Br J Dermatol. 1998;139 (Suppl 52):8-11

9. Patel VB, et al. Drug Dev Ind Pharm. 2001;27:863-869

10. Quigley JW, Bucks DA. J Am Acad Dermatol. 1998;38:S5-10

11. Brand B, et al. J Am Acad Dermatol. 2003;49 (3Suppl):S227-232.

Similar Articles

You may also start an advanced similarity search for this article.